Intervention Review

You have free access to this content

Optimal timing for intravascular administration set replacement

  1. Amanda J Ullman1,*,
  2. Marie L Cooke2,
  3. Donna Gillies3,
  4. Nicole M Marsh4,
  5. Azlina Daud5,
  6. Matthew R McGrail6,
  7. Elizabeth O'Riordan7,
  8. Claire M Rickard1

Editorial Group: Cochrane Anaesthesia Group

Published Online: 15 SEP 2013

Assessed as up-to-date: 12 JUN 2012

DOI: 10.1002/14651858.CD003588.pub3


How to Cite

Ullman AJ, Cooke ML, Gillies D, Marsh NM, Daud A, McGrail MR, O'Riordan E, Rickard CM. Optimal timing for intravascular administration set replacement. Cochrane Database of Systematic Reviews 2013, Issue 9. Art. No.: CD003588. DOI: 10.1002/14651858.CD003588.pub3.

Author Information

  1. 1

    Griffith University, NHMRC Centre of Research Excellence in Nursing, Centre for Health Practice Innovation, Griffith Health Institute, Brisbane, Queensland, Australia

  2. 2

    Griffith University, NHMRC Centre of Research Excellence in Nursing, Brisbane, Queensland, Australia

  3. 3

    Western Sydney Local Health District - Mental Health, Parramatta, NSW, Australia

  4. 4

    Royal Brisbane and Women's Hospital, Centre for Clinical Nursing, Brisbane, Queensland, Australia

  5. 5

    Griffith University, School of Nursing and Midwifery, Nathan, Queensland, Australia

  6. 6

    Monash University, Gippsland Medical School, Churchill, Victoria, Australia

  7. 7

    The University of Sydney and The Children's Hospital at Westmead, Faculty of Nursing and Midwifery, Sydney, New South Wales, Australia

*Amanda J Ullman, NHMRC Centre of Research Excellence in Nursing, Centre for Health Practice Innovation, Griffith Health Institute, Griffith University, 170 Kessels Road, Brisbane, Queensland, 4111, Australia. a.ullman@griffith.edu.au.

Publication History

  1. Publication Status: New search for studies and content updated (conclusions changed)
  2. Published Online: 15 SEP 2013

SEARCH

References

References to studies included in this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
  4. References to other published versions of this review
Blight 1998 {unpublished data only}
  • Blight I, Amadio J, Thomas P, Wilkinson I, Lusis I. Randomised prospective study of replacing intravenous administration sets at 72 hours versus 120 hour intervals in central venous catheters. 4th Nursing Practice Conference Book of Abstracts. Adelaide, Australia: Flinders University, 1998:3.
Buxton 1979 {published data only}
  • Buxton AE, Highsmith AK, Garner JS, West CM, Stamm WE, Dixon RE, et al. Contamination of intravenous infusion fluid: effects of changing administration sets. Annals of Internal Medicine 1979;90(5):764-8. [MEDLINE: 373560]
Covey 1988 {published data only}
  • Covey M, McLane C, Smith N, Matasic J, Holm K. Infection related to intravascular pressure monitoring: effects of flush and tubing changes. American Journal of Infection Control 1988;16(5):206-13. [PUBMED: 3195780]
deMoissac 1998 {published data only}
  • deMoissac D, Jensen L. Changing IV administration sets: is 48 versus 24 hours safe for neutropenic patients with cancer?. Oncology Nursing Forum 1998;25(5):907-13. [MEDLINE: 9644707]
Fox 1999 {published data only}
  • Fox M, Molesky M, Van Aerde JE, Muttitt S. Changing parenteral nutrition administration sets every 24 h versus every 48 h in newborn infants. Canadian Journal of Gastroenterology 1999;13(2):147-51. [MEDLINE: 10203434]
Gorbea 1984 {published data only}
Jakobsen 1986 {published data only}
  • Jakobsen CJ, Grabe N, Nielsen E, Hojbjerg T, Damm M, Lorentzen K, et al. Contamination of intravenous infusion systems-the effect of changing administration sets. Journal of Hospital Infection 1986;8(3):217-23. [MEDLINE: 2878025]
Josephson 1985 {published data only}
  • Josephson A, Gombert ME, Sierra MF, Karanfil LV, Tansino GF. The relationship between intravenous fluid contamination and the frequency of tubing replacement. Infection Control 1985;6(9):367-70. [MEDLINE: 3932250]
Luskin 1986 {published data only (unpublished sought but not used)}
Maki 1987 {published data only}
  • Maki DG, Botticelli JT, LeRoy ML, Thielke TS. Prospective study of replacing administration sets for intravenous therapy at 48- vs 72-hour intervals. 72 hours is safe and cost-effective. JAMA 1987;258(13):1777-81. [MEDLINE: 3114506]
  • Maki DG, Botticelli JT, LeRoy ML, Thielke TS. Prospective study of replacing administration sets for intravenous therapy at 48- vs 72-hour intervals: 72 hours is safe and cost-effective. CINA: Official Journal of the Canadian Intravenous Nurses Association 1990;6(4):12-6.
Matlow 1999 {published data only}
  • Matlow AG, Kitai I, Kirpalani H, Chapman NH, Corey M, Perlman M, et al. A randomised trial of 72 versus 24 hour intravenous tubing set changes in newborns receiving lipid therapy. Infection Control and Hospital Epidemiology 1999;20(7):487-93. [MEDLINE: 10432161]
McLane 1998 {published data only}
  • McLane C, Morris L, Holm K. A comparison of intravascular pressure monitoring system contamination and patient bacteremia with use of 48- and 72-hour system change intervals. Heart and Lung May/June 1998;27(3):200-8. [PUBMED: 9622407]
Raad 2001 {published data only}
  • Raad I, Hanna H, Richardson D, Abi-Saia D, Awad A, Alrahwan A, et al. Optimal frequency of changing intravenous administration sets (IVAS): is it safe to prolong duration of use beyond three days?. Infection Control and Hospital Epidemiology 1998;19(Suppl 9):682.
  • Raad I, Hanna HA, Awad A, Alrahwan A, Bivins C, Khan A, et al. Optimal frequency of changing intravenous administration sets: is it safe to prolong use beyond 72 hours?. Infection Control and Hospital Epidemiology 2001;22(3):136-9. [PUBMED: 11310690]
Rickard 2004 {published and unpublished data}
  • Rickard CM, Lipman J, Courtney M, Siversen R, Daley P. Routine changing of intravenous administration sets does not reduce colonization or infection in central venous catheters. Infection Control and Hospital Epidemiology 2004;25(8):650-5. [PUBMED: 15357156]
Sitges-Serra 1985 {published data only}
  • Sitges-Serra A, Linares J, Perez JL, Jaurrieta E, Lorente L. A randomized trial on the effect of tubing changes on hub contamination and catheter sepsis during parenteral nutrition. Journal of Parenteral and Enteral Nutrition 1985;9(3):322-5. [MEDLINE: 3925176]
Snydman 1987 {published data only}

References to studies excluded from this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
  4. References to other published versions of this review
Alothman 1996 {published data only}
  • Alothman A, Scharf S, Bryce EA. Extending central venous catheter tubing changes to five days: safety and cost effectiveness. Program and Abstracts of the IDSA 34th Annual Meeting. Arlington, Virginia: Infectious Diseases Society of America, 1996:861.
Band 1979 {published data only}
Chen 2000 {published data only}
  • Chen Y, Lin M, Lin MY, Wang FD, Liu JH, Chang MS. The central venous tubing change associated with catheter-related infection. Infection Control and Hospital Epidemiology 2000;21(2):94.
Cohen 1989 {published data only}
  • Cohen DM. A replication study: analysis of bacterial contamination of intravenous administration sets in use for 72 hours. Journal of the New York State Nurses Association 1989;20(3):12. [MEDLINE: 2778552]
Franceschi 1989 {published data only}
  • Franceschi D, Gerding RL, Phillips G, Fratianne RB. RIsk factors associated with intravascular catheter infections in burned patients: a prospective, randomized study. The Journal of Trauma 1989;29(6):811-6. [PUBMED: 2738979]
O'Malley 1994 {published data only}
Powell 1985 {published data only}
  • Powell CR, Traetow MJ, Fabri PJ, Kudsk KA, Ruberg RL. Op-Site dressing study: a prospective randomized study evaluating povidone iodine ointment and extension set changes with 7-day Op-Site dressings applied to total parenteral nutrition subclavian sites. Journal of Parenteral and Enteral Nutrition 1985;9(4):443-6. [MEDLINE: 3928918]
Robathan 1995 {published data only}
  • Robathan G, Woodger S, Merante D. A prospective study evaluating the effects of extending total parenteral nutrition line changes to 72 hours. Journal of Intravenous Nursing 1995;18(2):84-7. [MEDLINE: 7707174]
Robertson 1991 {published data only}
  • Robertson J. Changing central venous catheter lines: evaluation of a modification to clinical practice. Journal of Pediatric Oncology Nursing. 1991;8(4):173-9. [MEDLINE: 1930810]
Trautmann 1997 {published data only}

Additional references

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
  4. References to other published versions of this review
Al-Rawajfah 2012
  • Al-Rawajfah OM, Hewitt JB, Stetzer F, Cheema J. Length of stay and charges associated with health care-acquired bloodstream infections. American Journal of Infection Control 2012;40:227-32.
Collignon 1994
  • Collignon PJ. Intravascular catheter associated sepsis: a common problem. The Australian study on intravascular catheter associated sepsis. The Medical Journal of Australia 1994;161(6):374-8.
Crump 2000
Deeks 2011
  • Deeks JJ, Higgins JPT, Altman DG. Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPF, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. 5.1. Chichester (UK): John WIley & Sons, 2011.
Egger 1997
Gilbert 1986
  • Gilbert M, Gallagher SC, Eads M, Elmore MF. Microbial growth patterns in a total parenteral nutrition formulation containing lipid emulsion. Journal of Parenteral and Enteral Nutrition 1986;10(5):494-7.
Higgins 2011
  • Higgins JPT, Altman DG, Stern JAC. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. 5.1. Chichester (UK): John WIley & Sons, 2011.
Ishizuka 2008
  • Ishizuka M,  Nagata H,  Takagi K,  Kubota K. Total parenteral nutrition is a major risk factor for central venous catheter-related bloodstream infection in colorectal cancer patients receiving postoperative chemotherapy. European Surgical Research 2008;41(4):341-5.
Lefebvre 2011
  • Lefebvre C, Manheimer E, Glanville F. Chapter 6: Searching for studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. 5.1. Chichester (UK): John Wiley & Sons, 2011.
Liberati 2009
  • Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ionnidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009;339:b2700.
Maki 2006
  • Maki DG,  Kluger DM,  Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clinic Proceedings 2006;81(9):1159-71.
Mermel 2009
  • Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady N, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clinical Infectious Diseases 2009;49:1-45.
Moro 1994
  • Moro ML, Vigano EF, Cozzi Lepri A. Risk factors for central venous catheter-related infections in surgical and intensive care units. Infection Control and Hospital Epidemiology 1994;15(4):253-64.
Mulloy 1991
  • Mulloy RH, Jadavji T, Russell ML. Tunneled central venous catheter sepsis: risk factors in a pediatric hospital. Journal of Parenteral and Enteral Nutrition 1991;15(4):460-3.
O'Grady 2002
  • O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report 2002;51([RR-10]):1-29.
O'Grady 2011
  • O'Grady N, Alexander M, Burns L, Dellinger E, Garland J, et al. and the Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for the prevention of intravascular catheter-related infections. Clinical Journal of Infectious Diseases 2011 May;52(9):1087-99.
Pearson 1996
  • Pearson ML. Special communication. HICPAC guideline for prevention of intravascular device-related infections. Parts I and II. American Journal of Infection Control 1996;24(4):262-93.
Perlman 2007
  • Perlman SE,  Saiman L,  Larson EL. Risk factors for late-onset health care-associated bloodstream infections in patients in neonatal intensive care units. American Journal of Infection Control 2007;35(3):177-82.
Renaud 2001
  • Renaud B, Brun-Buisson C, ICU-Bacteremia Study Group. Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients. American Journal of Respiratory and Critical Care Medicine 2001;163(7):1584-90. [MEDLINE: 11401878]
RevMan 5.1
  • The Cochrane Collaboration. Review Manager (RevMan). 5.1 for Windows. Oxford, England: The Cochrane Collaboration, 2012.
Rickard 2001
  • Rickard C, Daley P, Lipman J, Davie A, Koroloff N, Siversen R, et al. Routine administration set changes do not reduce central venous catheter infection (abstract). Anaesthesia and Intensive Care 2001;29(2):185.
Schulz 2010
  • Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Annals of Internal Medicine 2010;152:726-32.
Schunemann 2011
  • Schunemann JH, Oxman AD, Higgins JPF, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. 5.1. Chichester (UK): John WIley & Sons, 2011.
Scott 1985
  • Scott EM, Gorman SP, Wyatt TD, Magill EA. Growth of microorganisms in total parenteral nutrition mixtures and related clinical observations. Journal of Clinical and Hospital Pharmacy 1985;10(1):79-88. [MEDLINE: 3923044]
Sherertz 1992
  • Sherertz RJ, Gledhill KS, Hampton KD, Pfaller MA, Givner LB, Abramson JS, et al. Outbreak of Candida bloodstream infections associated with retrograde medication administration in a neonatal intensive care unit. Journal of Pediatrics 1992;120(3):455-61. [MEDLINE: 1538298]
Shiro 1995
Soufir 1999
  • Soufir L, Timsit JF, Mahe C, Carlet J, Regnier B, Chevret S. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study. Infection Control and Hospital Epidemiology 1999;20(6):396-401. [MEDLINE: 10395140]

References to other published versions of this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
  4. References to other published versions of this review
Gillies 2004
Gillies 2005